Work

1871 Inhibition of mTOR in combination with chemotherapy and angiogenic blockade shows activity in metaplastic breast cancer, an aggressive, chemo-refractory subtype of triple-negative breast cancer (TNBC)

Year: 2015

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(16)30821-8

Authors: R. Basho, F. Janku, T. Helgason, M. Gilcrease, D. Booser, D. Karp, F. Meric-Bernstam, J. Wheler, V. Valero, C. Albarracin, J. Litton, M. Chavez-MacGregor, N. Ibrahim, J. Murray, K. Koenig, D. Hong, V. Subbiah, R. Kurzrock, S. Moulder

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2514580150

FWCI: 0.145

Cites:

Cited by: 1

Related to: 10